Company: BIAF
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010787
Chunk: 51

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 51
---
 
  
    Medical director fees 
     11,600  
     5,194 
  
    Other receivables 
     17,381  
     27,874 
  
    Total accounts and other receivables, net 
    $963,744  
    $1,139,204 

Note 4. PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid expenses and other current assets are summarized
below:

SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS 

    March 31, 2025

    December 31, 2024

    Prepaid insurance
     
    $
    160,756

    $
    248,364

    Legal and professional

    15,787

    27,448

    Other

    240,007

    147,183

    Total prepaid expenses and other current assets
     
    $
    416,550

    $
    422,995

    13

Note 5. PROPERTY AND EQUIPMENT, NET

Property and equipment are summarized below:

SCHEDULE OF PROPERTY AND EQUIPMENT 

    March 31, 2025  
    December 31, 2024 

    Lab equipment 
    $679,995  
    $662,747 
  
    Computers and software 
     81,433  
     81,433 
  
    Leasehold improvements 
     19,353  
     19,353 
  
    Vehicles 
     181,640  
     148,103 
  
    Property
    and equipment, gross 
     962,421  
     911,636 
  
    Less: accumulated depreciation and amortization 
     (580,012) 
     (536,251)
  
    Total property and equipment, net 
    $382,409  
    $375,385 

Depreciation expense was $43,763 and $38,811 for the
three months ended March 31, 2025 and 2024, respectively.

Note 6. ACCRUED EXPENSES

Accrued expenses are summarized below:

SCHEDULE OF ACCRUED EXPENSES 

    March 31, 2025  
    December 31, 2024 

    Compensation 
    $932,208  
    $1,079,839 
  
    Legal and